DBIBB – 10 mg

Brand:
Cayman
CAS:
1569309-92-7
Storage:
-20
UN-No:
Non-Hazardous - /

The lysophosphatidic acid (LPA) receptor LPA2 is a G protein-coupled receptor that has roles in protecting against radiation-induced cell death.{29230} DBIBB is a non-lipid agonist of LPA2 (EC50 = 0.10 µM) that is without effect at other LPA receptor subtypes.{28449} It protects rat intestinal crypt epithelium-like IEC-6 cells against caspase 3/7 activation and apoptosis following irradiation.{28449} DBIBB dose-dependently attenuates radiation-induced DNA damage in mouse embryo fibroblasts (MEFs) expressing LPA2 but not in MEFs lacking this receptor.{28449} It also increases the survival of mice suffering from hematopoietic acute radiation syndrome after total-body irradiation.{28449}  

 

Available on backorder

SKU: - Category:

Description

A non-lipid agonist of LPA2 (EC50 = 0.10 µM) that is without effect at other LPA receptor subtypes; protects IEC-6 cells against caspase activation and apoptosis following irradiation; increases the survival of mice suffering from hematopoietic acute radiation syndrome after total-body irradiation


Formal name: 2-[[[4-(1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl)butyl]amino]sulfonyl]-benzoic acid

Synonyms: 

Molecular weight: 452.5

CAS: 1569309-92-7

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Immunology & Inflammation|Innate Immunity